Cargando…
MED12 exon 2 mutations in phyllodes tumors of the breast
Exon 2 of MED12, a subunit of the transcriptional mediator complex, has been frequently mutated in uterine leiomyomas and breast fibroadenomas; however, it has been rarely mutated in other tumors. Although the mutations were also found in uterine leiomyosarcomas, the frequency was significantly lowe...
Autores principales: | Nagasawa, Satoi, Maeda, Ichiro, Fukuda, Takayo, Wu, Wenwen, Hayami, Ryosuke, Kojima, Yasuyuki, Tsugawa, Ko-ichiro, Ohta, Tomohiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4529349/ https://www.ncbi.nlm.nih.gov/pubmed/25865354 http://dx.doi.org/10.1002/cam4.462 |
Ejemplares similares
-
Class I histone deacetylase inhibitors inhibit the retention of BRCA1 and 53BP1 at the site of DNA damage
por: Fukuda, Takayo, et al.
Publicado: (2015) -
Frequent MED12 mutations in phyllodes tumours of the breast
por: Yoshida, M, et al.
Publicado: (2015) -
LSD1 Overexpression Is Associated with Poor Prognosis in Basal-Like Breast Cancer, and Sensitivity to PARP Inhibition
por: Nagasawa, Satoi, et al.
Publicado: (2015) -
Genomic profiling reveals heterogeneous populations of ductal carcinoma in situ of the breast
por: Nagasawa, Satoi, et al.
Publicado: (2021) -
MED12, TERT promoter and RBM15 mutations in primary and
recurrent phyllodes tumours
por: Garcia-Dios, Diego A, et al.
Publicado: (2018)